To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases
CRISPR/Cas has emerged as an excelle nt gene-editing technology and is used worldwide for research. The CRISPR library is an ideal tool for identifying essential genes and synthetic lethality targeted for cancer therapies in human cancers. Synthetic lethality is defined as multiple genetic abnormali...
Enregistré dans:
| Auteurs principaux: | Iichiroh Onishi, Kouhei Yamamoto, Yuko Kinowaki, Masanobu Kitagawa, Morito Kurata |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/875a5219042e49beb189ce78fc532fab |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors
par: Klara Klein, et autres
Publié: (2021) -
Development of a CRISPR/Cas9-Based Tool for Gene Deletion in <italic toggle="yes">Issatchenkia orientalis</italic>
par: Vinh G. Tran, et autres
Publié: (2019) -
Bioinformational analysis of Yersinia pseudotuberculosis IP32953 CRISPR/cas system
par: N. P. Peretolchina, et autres
Publié: (2016) -
Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein
par: April Pawluk, et autres
Publié: (2017) -
High‐efficiency delivery of CRISPR‐Cas9 by engineered probiotics enables precise microbiome editing
par: Kevin Neil, et autres
Publié: (2021)